SILEXION THERAPEUTICS CORP Class of Warrant or Right, Outstanding
SILEXION THERAPEUTICS CORP (SLXN) had Class of Warrant or Right, Outstanding of 62 shares as of 2024-08-06, per its 8-K filed 2025-08-20.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-08-20
- 2024-08-06: Class of Warrant or Right, Outstanding 62.00 shares; Class of Warrant or Right, Outstanding as first filed 8.21K shares.
- 2024-06-30: Class of Warrant or Right, Outstanding 21.72K shares.
- 2023-06-30: Class of Warrant or Right, Outstanding 47.49K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2024-08-06 | 62.00 shares 8-K · filed 2025-08-20 | 8.21K shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 21.72K shares 10-Q · filed 2024-08-29 | |
| 2023-06-30 | 47.49K shares 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |